EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Lu J, Tang M, Li H, Xu Z, Weng X, Li J, Yu X, Zhao L, Liu H, Hu Y, Tan Z, Yang L, Zhong M, Zhou J, Fan J, Bode AM, Yi W, Gao J, Sun L, Cao Y.
Lu J, et al. Among authors: li j, li h.
Cancer Lett. 2016 Sep 28;380(1):191-200. doi: 10.1016/j.canlet.2016.05.032. Epub 2016 May 30.
Cancer Lett. 2016.
PMID: 27255972